<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01344499</url>
  </required_header>
  <id_info>
    <org_study_id>S52808</org_study_id>
    <nct_id>NCT01344499</nct_id>
  </id_info>
  <brief_title>Clearance Rate of Peritoneal Fluid After Full Conditioning Pneumoperitoneum</brief_title>
  <official_title>Clearance Rate of Peritoneal Fluid Assessed by Post-operative Ultrasound Decreases After Full Conditioning Pneumoperitoneum</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Gasthuisberg</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital, Gasthuisberg</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Measurement of residual peritoneal fluid after laparoscopic surgery
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Primary endpoints

        -  to evaluate whether the clearance rate of peritoneal fluid is exponential or linear over
           time. (absorption rate expected for Adept ~30-60 ml/h)

        -  to evaluate the role of the mesothelial barrier in this clearance rate.

      Knowing that diffusion to and from peritoneal fluid decreases with increasing molecular
      weight (MW), our hypothesis is that clearance rate will decrease following peritoneal
      conditioning. Indeed a decreased mesothelial trauma (either through hypoxia or through
      denudation) and retraction will expose less the basal membrane

      Secondary endpoints:

      -To confirm the decrease in post-operative pain as measured by VAS-score and inflammation as
      measured by CRP and leucocytosis with the full conditioning of the pneumoperitoneum.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>August 2009</start_date>
  <completion_date type="Actual">September 2011</completion_date>
  <primary_completion_date type="Actual">September 2011</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>clearance rate of peritoneal fluid</measure>
    <time_frame>3 days after surgery</time_frame>
    <description>We will estimate the residual volume of fluid in the abdominal cavity in a 30° anti-Trendelenburg position after 1 minute in this position. Measurements will be repeated daily until discharge.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Pain and inflammation score</measure>
    <time_frame>3 days after surgery</time_frame>
    <description>Postoperative pain will be assessed by the intake of ibuprofen or other pain killers and by Visual Analog Scale (VAS). Patients will be asked to locate their pain-symptoms (shoulder, subcostal, trocar wound and visceral pain) and score the severity. VAS will be collected 2-4 hours after surgery and every post-operative day until discharge.
Daily routine blood samples will be obtained and CRP will be measured. Routinely time of first flatus or stools will be recorded</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">20</enrollment>
  <condition>Laparoscopic Hysterectomy</condition>
  <arm_group>
    <arm_group_label>Adept</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>1000ml Adept will be left in the abdomen and measured over time</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Ringer-lactate</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>1000 ml of Ringer lactate left in the abdomen and measured over time</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Carbon dioxide</intervention_name>
    <description>standard pneumoperitoneum with 100% CO2</description>
    <arm_group_label>Adept</arm_group_label>
    <arm_group_label>Ringer-lactate</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>full conditioning</intervention_name>
    <description>Pneumoperitoneum with CO2 + 4% of oxygen + 10% nitrous oxide + 100% RH + T° 32°C</description>
    <arm_group_label>Adept</arm_group_label>
    <arm_group_label>Ringer-lactate</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Adept</intervention_name>
    <description>instillation of 1 liter of fluid at the end of laparoscopy</description>
    <arm_group_label>Adept</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Ringer Lactate</intervention_name>
    <description>instillation of 1 liter of fluid at the end of laparoscopy</description>
    <arm_group_label>Ringer-lactate</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Women planned to undergo a total or subtotal laparoscopic hysterectomy and having
             signed the informed consent.

          -  No limitation in body mass index or uterine size is made.

        Exclusion Criteria:

          -  pregnancy

          -  immunodeficiency

          -  refuse or unable to sign informed consent

          -  chronic disease (i.e. COPD, Crohn, cardiac…)

          -  known allergy for Adept©
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>JAsper Verguts, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>UZ Leuven</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>UZ Leuven, campus Gasthuisberg</name>
      <address>
        <city>Leuven</city>
        <zip>3000</zip>
        <country>Belgium</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Belgium</country>
  </location_countries>
  <verification_date>June 2013</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 21, 2011</study_first_submitted>
  <study_first_submitted_qc>April 27, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 29, 2011</study_first_posted>
  <last_update_submitted>June 3, 2013</last_update_submitted>
  <last_update_submitted_qc>June 3, 2013</last_update_submitted_qc>
  <last_update_posted type="Estimate">June 4, 2013</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University Hospital, Gasthuisberg</investigator_affiliation>
    <investigator_full_name>Jasper Verguts</investigator_full_name>
    <investigator_title>MD, PhD</investigator_title>
  </responsible_party>
  <keyword>women</keyword>
  <keyword>laparoscopic subtotal hysterectomy</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pneumoperitoneum</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Icodextrin</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

